Intrexon Launches Leadership Platform in Bovine Genetics
Thursday, August 14, 2014
Intrexon Corporation (NYSE: XON), has completed the acquisition of Trans Ova Genetics, L.C., a provider of bovine reproductive technologies. Trans Ova, as a wholly owned subsidiary of Intrexon, will operate under the leadership of David Faber, D.V.M., President, and his management team.
"With continued expansion of the world's population, the present approaches to produce food and protein are in need of transformational reproductive technologies to drive a sustainable path forward for current and future generations," said Dr. Faber. "The combined capabilities and expertise of Intrexon and Trans Ova supply the means to enhance the rate of genetic progress globally, providing cattle farmers superior productivity and efficient utilization of resources in an environmentally responsible manner."
In addition to its expertise in embryo transfer, cryopreservation, in vitro fertilization, and genetic preservation, Trans Ova has platforms for the design and development of research animal models, as well as proficiency in reproducing the favorable genetics of one animal in another. Furthermore Trans Ova's ability to rapidly propagate elite bovine and porcine genetics holds the potential to transform, and in conjunction with OvaXon's pioneering fertility technologies, meaningfully accelerate the rate of efficient food production derived from cattle and pigs. OvaXon, a joint venture between Intrexon and OvaScience (NASDAQ: OVAS), recently licensed its technology to Trans Ova.
Thomas R. Kasser, Ph.D., Senior Vice President and Head of Intrexon's Food Sector, spoke of the integration, "Together with Intrexon's broad technology platform in both food and animal health, Trans Ova is well positioned to develop and implement new tools and reproductive technologies that will help move the science of genetic improvement in animals forward, enabling unparalleled productivity advancements in the dairy, beef and pork industries."